0001415889-24-002305.txt : 20240202 0001415889-24-002305.hdr.sgml : 20240202 20240202163523 ACCESSION NUMBER: 0001415889-24-002305 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240131 FILED AS OF DATE: 20240202 DATE AS OF CHANGE: 20240202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ferguson Matthew CENTRAL INDEX KEY: 0001304079 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39577 FILM NUMBER: 24592102 MAIL ADDRESS: STREET 1: C/O FOXHOLLOW TECHNOLOGIES, INC. STREET 2: 740 BAY ROAD CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ELUTIA INC. CENTRAL INDEX KEY: 0001708527 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474790334 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12510 PROSPERITY DRIVE STREET 2: SUITE 370 CITY: SILVER SPRING STATE: MD ZIP: 20904 BUSINESS PHONE: 240-247-1143 MAIL ADDRESS: STREET 1: 12510 PROSPERITY DRIVE STREET 2: SUITE 370 CITY: SILVER SPRING STATE: MD ZIP: 20904 FORMER COMPANY: FORMER CONFORMED NAME: AZIYO BIOLOGICS, INC. DATE OF NAME CHANGE: 20170605 4 1 form4-02022024_090206.xml X0508 4 2024-01-31 0001708527 ELUTIA INC. ELUT 0001304079 Ferguson Matthew C/O ELUTIA INC. 12510 PROSPERITY DRIVE, SUITE 370 SILVER SPRING MD 20904 false true false false CHIEF FINANCIAL OFFICER 0 Stock Option (Right to Buy) 3.61 2024-01-31 4 A 0 150000 0 A 2034-01-31 Class A Common Stock 150000 150000 D Restricted Stock Units 2024-01-31 4 A 0 150000 0 A Class A Common Stock 150000 150000 D Restricted Stock Units 2024-01-31 4 A 0 50000 0 A Class A Common Stock 50000 50000 D The option vests monthly over three years beginning one month after grant date such that the option shall be fully vested and exercisable on January 31, 2027. Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock. The restricted stock units vest as to 1/6 on June 10, 2024, and vest as to 1/12 quarterly on each of the following dates: September 10, 2024, December 10, 2024, March 10, 2025, June 10, 2025, September 10, 2025, December 10, 2025, March 10, 2026, June 10, 2026, September 10, 2026, and December 10, 2026. The restricted stock units vest as to 34% on September 10, 2024, 33% on March 10, 2025 and 33% on September 10, 2025. /s/ Jeffrey Hamet, Attorney-in-Fact for Matthew Ferguson 2024-02-02